Nurami Medical
PrivateLast Round
Series C
Mar 4, 2025
Total Funding Raised
$46.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nurami Medical operates in Healthcare & Life Sciences and is based in Haifa. Its latest recorded funding round was a Series C round in March 2025.
Nurami Medical is a biotechnology company that develops and manufactures nanofiber-based products for soft tissue repair.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nurami Medical Comparables
Compare Nurami Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pramand | 88% | |
| Neomend | 86% | |
| Medprin Regenerative Medical Technologies Co. Ltd. | 84% |
For institutional investors. Book with your work email.
Nurami Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 4, 2025 | ||||
| Grant | Jul 16, 2024 | ||||
| Grant | Jul 2, 2024 | ||||
| Series B | Nov 2, 2020 | ||||
| VC Round | Jul 16, 2019 | ||||
Series A | Jul 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nurami Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| huMannity Medtec | VC Round, Seed |
| Israel Innovation Authority | Grant, VC Round |
| Next Generation Technology (NGT3VC) | Grant |
| GlenRock Israel | Series B |
| Almeda Ventures | Series B |
| Iron Nation | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 141% MoM, reaching 450.
- Jul 16, 2024
Secured $3M from European Innovation Council Fund and Israel Innovation Authority.
For institutional investors. Book with your work email.
Nurami Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nurami Medical's valuation, stock price, and market status.
Is Nurami Medical a public or private company?
Nurami Medical is a private company.
What is the current stock price of Nurami Medical?
Nurami Medical is a private company, so its shares have no public market price. Caplight tracks Nurami Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nurami Medical worth (valuation)?
Valuation information for Nurami Medical is not publicly available.
Can I buy Nurami Medical stock?
Nurami Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nurami Medical's last funding round?
Nurami Medical's most recent funding round was Series C on March 4, 2025.
Who are the main investors in Nurami Medical?
Key investors in Nurami Medical include huMannity Medtec, Almeda Ventures.
Will Nurami Medical IPO soon?
No public IPO plans have been announced for Nurami Medical.
How can I track Nurami Medical secondary market activity?
Caplight tracks bids, offers, and trades in Nurami Medical's shares on secondary markets.